147 related articles for article (PubMed ID: 26445057)
1. HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells.
Sun P; Dong L; MacDonald AI; Akbari S; Edward M; Hodgins MB; Johnstone SR; Graham SV
Viruses; 2015 Oct; 7(10):5243-56. PubMed ID: 26445057
[TBL] [Abstract][Full Text] [Related]
2. A functional interaction between the MAGUK protein hDlg and the gap junction protein connexin 43 in cervical tumour cells.
Macdonald AI; Sun P; Hernandez-Lopez H; Aasen T; Hodgins MB; Edward M; Roberts S; Massimi P; Thomas M; Banks L; Graham SV
Biochem J; 2012 Aug; 446(1):9-21. PubMed ID: 22657348
[TBL] [Abstract][Full Text] [Related]
3. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.
Lichtig H; Algrisi M; Botzer LE; Abadi T; Verbitzky Y; Jackman A; Tommasino M; Zehbe I; Sherman L
Virology; 2006 Jun; 350(1):216-27. PubMed ID: 16519914
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
Liu Y; Henry GD; Hegde RS; Baleja JD
Biochemistry; 2007 Sep; 46(38):10864-74. PubMed ID: 17713926
[TBL] [Abstract][Full Text] [Related]
5. Association of cottontail rabbit papillomavirus E6 oncoproteins with the hDlg/SAP97 tumor suppressor.
Du M; Fan X; Hanada T; Gao H; Lutchman M; Brandsma JL; Chishti AH; Chen JJ
J Cell Biochem; 2005 Apr; 94(5):1038-45. PubMed ID: 15669058
[TBL] [Abstract][Full Text] [Related]
6. The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg.
Narayan N; Subbaiah VK; Banks L
Virology; 2009 Apr; 387(1):1-4. PubMed ID: 19307009
[TBL] [Abstract][Full Text] [Related]
7. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
8. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.
Kiyono T; Hiraiwa A; Fujita M; Hayashi Y; Akiyama T; Ishibashi M
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11612-6. PubMed ID: 9326658
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation.
Jeong KW; Kim HZ; Kim S; Kim YS; Choe J
Oncogene; 2007 Jan; 26(4):487-99. PubMed ID: 16878151
[TBL] [Abstract][Full Text] [Related]
10. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
11. E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein.
Handa K; Yugawa T; Narisawa-Saito M; Ohno S; Fujita M; Kiyono T
J Virol; 2007 Feb; 81(3):1379-89. PubMed ID: 17121805
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor.
Mori S; Takeuchi T; Ishii Y; Yugawa T; Kiyono T; Nishina H; Kukimoto I
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077648
[TBL] [Abstract][Full Text] [Related]
13. A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein.
Dymalla S; Scheffner M; Weber E; Sehr P; Lohrey C; Hoppe-Seyler F; Hoppe-Seyler K
J Mol Med (Berl); 2009 Mar; 87(3):321-31. PubMed ID: 19099279
[TBL] [Abstract][Full Text] [Related]
14. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.
Watson RA; Thomas M; Banks L; Roberts S
J Cell Sci; 2003 Dec; 116(Pt 24):4925-34. PubMed ID: 14625386
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein.
Facciuto F; Bugnon Valdano M; Marziali F; Massimi P; Banks L; Cavatorta AL; Gardiol D
Mol Oncol; 2014 May; 8(3):533-43. PubMed ID: 24462519
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation.
Massimi P; Narayan N; Cuenda A; Banks L
Oncogene; 2006 Jul; 25(31):4276-85. PubMed ID: 16532034
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization and quantitation of the human papillomavirus type 16 E6 oncoprotein through immunocytochemistry detection.
Jackson R; Togtema M; Zehbe I
Virology; 2013 Jan; 435(2):425-32. PubMed ID: 23084288
[TBL] [Abstract][Full Text] [Related]
18. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
19. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.
Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324
[TBL] [Abstract][Full Text] [Related]
20. Changes in global gene expression profiles induced by HPV 16 E6 oncoprotein variants in cervical carcinoma C33-A cells.
Zacapala-Gómez AE; Del Moral-Hernández O; Villegas-Sepúlveda N; Hidalgo-Miranda A; Romero-Córdoba SL; Beltrán-Anaya FO; Leyva-Vázquez MA; Alarcón-Romero Ldel C; Illades-Aguiar B
Virology; 2016 Jan; 488():187-95. PubMed ID: 26655236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
